Dengyao Jia
CIK: 0002080036
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (0 total)
2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Jia Dengyao
Jia Dengyao (SEC CIK 0002080036) files insider reports with the SEC as Director of Lianhe Sowell International Group Ltd (LHSW) and Director of Estrella Immunopharma, Inc. (ESLA).
Signal8 holds 2 ownership filings by Jia Dengyao, all Form 3s, filed between Oct 1, 2025 and Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Jia Dengyao's filings is in SHENZHEN.
Other insiders filing for Lianhe Sowell International Group Ltd (LHSW)
- Zhu Yue, CEO
- WONG HOI HIN, Director
- Ng Tracy Chui-Kam, Chief Financial Officer
- Chow Chun Yu Leeds, Director
- Ling Yong, Director